270 related articles for article (PubMed ID: 15258793)
1. Peripheral neuropathy in HTLV-I infected individuals without tropical spastic paraparesis/HTLV-I-associated myelopathy.
Leite AC; Silva MT; Alamy AH; Afonso CR; Lima MA; Andrada-Serpa MJ; Nascimento OJ; Araújo AQ
J Neurol; 2004 Jul; 251(7):877-81. PubMed ID: 15258793
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of peripheral neuropathy in patients with HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Saeidi M; Sasannejad P; Foroughipour M; Shahami S; Shoeibi A
Acta Neurol Belg; 2011 Mar; 111(1):41-4. PubMed ID: 21510232
[TBL] [Abstract][Full Text] [Related]
3. Sensory neuronopathy heralding human T cell lymphotropic virus type I myelopathy.
Martinez ARM; Casseb RF; Martins CR; Nucci A; França MC
J Neurovirol; 2018 Jun; 24(3):369-371. PubMed ID: 29318453
[TBL] [Abstract][Full Text] [Related]
4. The clinical and pathological features of peripheral neuropathy accompanied with HTLV-I associated myelopathy.
Kiwaki T; Umehara F; Arimura Y; Izumo S; Arimura K; Itoh K; Osame M
J Neurol Sci; 2003 Jan; 206(1):17-21. PubMed ID: 12480079
[TBL] [Abstract][Full Text] [Related]
5. HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP): the role of HTLV-I-infected Th1 cells in the pathogenesis, and therapeutic strategy.
Nakamura T
Folia Neuropathol; 2009; 47(2):182-94. PubMed ID: 19618340
[TBL] [Abstract][Full Text] [Related]
6. Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients.
Casseb J; de Oliveira AC; Vergara MP; Montanheiro P; Bonasser F; Meilman Ferreira C; Smid J; Duarte AJ
J Med Virol; 2008 Mar; 80(3):392-8. PubMed ID: 18205234
[TBL] [Abstract][Full Text] [Related]
7. Temporal lesions and widespread involvement of white matter associated with multi-organ inflammatory disease in human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Mendes GB; Kalil RS; Rosadas C; de Freitas MR; Puccioni-Sohler M
Int J Infect Dis; 2014 Aug; 25():1-3. PubMed ID: 24815740
[TBL] [Abstract][Full Text] [Related]
8. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
[TBL] [Abstract][Full Text] [Related]
9. Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP.
Grassi MF; Olavarria VN; Kruschewsky Rde A; Mascarenhas RE; Dourado I; Correia LC; de Castro-Costa CM; Galvão-Castro B
J Med Virol; 2011 Jul; 83(7):1269-74. PubMed ID: 21567429
[TBL] [Abstract][Full Text] [Related]
10. [Neurological symptoms and disability in HTLV-1 associated myelopathy].
Carod-Artal FJ; Mesquita HM; Ribeiro Lda S
Neurologia; 2008 Mar; 23(2):78-84. PubMed ID: 18322825
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus and human T-cell lymphotropic virus type 1 co-infection: impact on liver disease, virological markers, and neurological outcomes.
Espíndola OM; Vizzoni AG; Lampe E; Andrada-Serpa MJ; Araújo AQC; Leite ACC
Int J Infect Dis; 2017 Apr; 57():116-122. PubMed ID: 28185943
[TBL] [Abstract][Full Text] [Related]
12. [Pathophysiology, treatment and biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)].
Yamano Y; Sato T
Nihon Rinsho; 2013 May; 71(5):870-5. PubMed ID: 23777097
[TBL] [Abstract][Full Text] [Related]
13. Co-presentation of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis and adult-onset infective dermatitis associated with HTLV-1 infection.
Okajima R; Casseb J; Sanches JA
Int J Dermatol; 2013 Jan; 52(1):63-8. PubMed ID: 23278610
[TBL] [Abstract][Full Text] [Related]
14. Infective dermatitis and human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in childhood and adolescence.
Primo JR; Brites C; Oliveira Mde F; Moreno-Carvalho O; Machado M; Bittencourt AL
Clin Infect Dis; 2005 Aug; 41(4):535-41. PubMed ID: 16028164
[TBL] [Abstract][Full Text] [Related]
15. Incidence of human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in a long-term prospective cohort study of initially asymptomatic individuals in Brazil.
Romanelli LC; Caramelli P; Martins ML; Gonçalves DU; Proietti FA; Ribas JG; Araújo MG; Carneiro-Proietti AB
AIDS Res Hum Retroviruses; 2013 Sep; 29(9):1199-202. PubMed ID: 23617363
[TBL] [Abstract][Full Text] [Related]
16. High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development.
Espíndola OM; Oliveira LC; Ferreira PM; Leite AC; Lima MA; Andrada-Serpa MJ
Intervirology; 2015; 58(2):106-14. PubMed ID: 25833232
[TBL] [Abstract][Full Text] [Related]
17. Neurological manifestations in HTLV-I-infected blood donors.
Leite AC; Mendonça GA; Serpa MJ; Nascimento OJ; Araújo AQ
J Neurol Sci; 2003 Oct; 214(1-2):49-56. PubMed ID: 12972388
[TBL] [Abstract][Full Text] [Related]
18. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
Gessain A; Mahieux R
Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
[TBL] [Abstract][Full Text] [Related]
19. Immunopathogenesis and neurological manifestations associated to HTLV-1 infection.
Souza A; Tanajura D; Toledo-Cornell C; Santos S; Carvalho EM
Rev Soc Bras Med Trop; 2012 Oct; 45(5):545-52. PubMed ID: 23152334
[TBL] [Abstract][Full Text] [Related]
20. Disulfide-mediated apoptosis of human T-lymphotrophc virus type-I (HTLV-I)-infected cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
Nishiura Y; Nakamura T; Fukushima N; Nakamura H; Ida H; Aramaki T; Eguchi K
Antivir Ther; 2009; 14(4):533-42. PubMed ID: 19578238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
